ArticleVaccine: X2025

Safety and durability of the immune response after vaccination with the heterologous schedule of anti-COVID-19 vaccines SOBERANA®02 and SOBERANA® Plus in children 3-18 years old.

Dagmar García-Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.